All news

Our abstract has been accepted for ICS 2024, which will be held in Madrid

International Continence Society 2024 congress logo

Finally, the first clinical study results with our T-Control urinary catheter will be presented in public, at the International Continence Society´s Congress 2024, in Madrid. We are happy to have the chance to connect with attendees from all around the world. A huge step towards making T-Control available for patients soon.

Related links

More news

Alba Jiménez Martel, Industrial Engineer, at her desk in the Rethink Medical office

Rethink Medical strengthens its R&D team to advance T-Control® development

Rethink Medical has welcomed Industrial Engineer Alba Jiménez Martel to strengthen its innovation team and contribute to the development of a new catheterisation solution aimed at addressing complex urinary catheterisation situations. The project includes the design and development of a new catheter tip and is supported through the IPI programme.

IPI Project · ESF+